Celldex Therapeutics, Inc.
$16.84
Stock Quotes & Analysis
CLDX5.65%
$16.84
Latest AAPL News (Need to figure out how to make this dynamic)
Graphene is an excellent conductor of electricity and heat, surpassing traditional materials like silicon, and…
The ballots have been counted, the speeches have been made, and the confetti has settled.…
The political winds are shifting, and Wall Street is taking notice. As Donald Trump’s approval…
In the shadows of Silicon Valley’s AI frenzy, a sleeping giant is awakening. While tech…
Celldex Therapeutics, Inc.Status: Active
Sector: Healthcare
Industry: Biotechnology
Symbol: CLDX
Exchange: NCM
Employees: 160
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.
 | Perryville III Building, Hampton, NJ, United States |
 | 908 200 7500 |
 | https://www.celldex.com |